Lee, H.J.; Jo, Y.; Wei, S.; Yu, E.H.; Lee, S.; Ryu, D.; Joo, J.K.
Fibroblast Activation Protein (FAP) as a Serum Biomarker for Fibrotic Ovarian Aging: A Clinical Validation Study Based on Translational Transcriptomic Targets. Int. J. Mol. Sci. 2025, 26, 7807.
https://doi.org/10.3390/ijms26167807
AMA Style
Lee HJ, Jo Y, Wei S, Yu EH, Lee S, Ryu D, Joo JK.
Fibroblast Activation Protein (FAP) as a Serum Biomarker for Fibrotic Ovarian Aging: A Clinical Validation Study Based on Translational Transcriptomic Targets. International Journal of Molecular Sciences. 2025; 26(16):7807.
https://doi.org/10.3390/ijms26167807
Chicago/Turabian Style
Lee, Hyun Joo, Yunju Jo, Shibo Wei, Eun Hee Yu, Sul Lee, Dongryeol Ryu, and Jong Kil Joo.
2025. "Fibroblast Activation Protein (FAP) as a Serum Biomarker for Fibrotic Ovarian Aging: A Clinical Validation Study Based on Translational Transcriptomic Targets" International Journal of Molecular Sciences 26, no. 16: 7807.
https://doi.org/10.3390/ijms26167807
APA Style
Lee, H. J., Jo, Y., Wei, S., Yu, E. H., Lee, S., Ryu, D., & Joo, J. K.
(2025). Fibroblast Activation Protein (FAP) as a Serum Biomarker for Fibrotic Ovarian Aging: A Clinical Validation Study Based on Translational Transcriptomic Targets. International Journal of Molecular Sciences, 26(16), 7807.
https://doi.org/10.3390/ijms26167807
